125 related articles for article (PubMed ID: 34479975)
1. Spatiofunctional Dynamics of NKX3.1 to Safeguard the Prostate from Cancer.
Finch AJ; Baena E
Cancer Discov; 2021 Sep; 11(9):2132-2134. PubMed ID: 34479975
[TBL] [Abstract][Full Text] [Related]
2. NKX3.1 Localization to Mitochondria Suppresses Prostate Cancer Initiation.
Papachristodoulou A; Rodriguez-Calero A; Panja S; Margolskee E; Virk RK; Milner TA; Martina LP; Kim JY; Di Bernardo M; Williams AB; Maliza EA; Caputo JM; Haas C; Wang V; De Castro GJ; Wenske S; Hibshoosh H; McKiernan JM; Shen MM; Rubin MA; Mitrofanova A; Dutta A; Abate-Shen C
Cancer Discov; 2021 Sep; 11(9):2316-2333. PubMed ID: 33893149
[TBL] [Abstract][Full Text] [Related]
3. Loss of glutathione peroxidase 3 induces ROS and contributes to prostatic hyperplasia in Nkx3.1 knockout mice.
Kim U; Kim CY; Lee JM; Ryu B; Kim J; Bang J; Ahn N; Park JH
Andrology; 2020 Sep; 8(5):1486-1493. PubMed ID: 32450005
[TBL] [Abstract][Full Text] [Related]
4. Antioxidant treatment promotes prostate epithelial proliferation in Nkx3.1 mutant mice.
Martinez EE; Anderson PD; Logan M; Abdulkadir SA
PLoS One; 2012; 7(10):e46792. PubMed ID: 23077524
[TBL] [Abstract][Full Text] [Related]
5. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression.
Papachristodoulou A; Heidegger I; Virk RK; Di Bernardo M; Kim JY; Laplaca C; Picech F; Schäfer G; De Castro GJ; Hibshoosh H; Loda M; Klocker H; Rubin MA; Zheng T; Benson MC; McKiernan JM; Dutta A; Abate-Shen C
Eur Urol; 2024 Apr; 85(4):361-372. PubMed ID: 37659962
[TBL] [Abstract][Full Text] [Related]
6. [A multi-omics study on NKX3.1-related node genes in prostate cancer].
Mo LJ; Su SQ; Gu YM; Hy YL
Zhonghua Nan Ke Xue; 2016 Apr; 22(4):294-9. PubMed ID: 30088395
[TBL] [Abstract][Full Text] [Related]
7. Oxidative DNA Damage-Mediated Genomic Heterogeneity Is Regulated by NKX3.1 in Prostate Cancer.
Debelec-Butuner B; Bostancı A; Ozcan F; Singin O; Karamil S; Aslan M; Roggenbuck D; Korkmaz KS
Cancer Invest; 2019; 37(2):113-126. PubMed ID: 30836777
[TBL] [Abstract][Full Text] [Related]
8. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
9. Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis.
Song H; Zhang B; Watson MA; Humphrey PA; Lim H; Milbrandt J
Oncogene; 2009 Sep; 28(37):3307-19. PubMed ID: 19597465
[TBL] [Abstract][Full Text] [Related]
10. Nkx3.1 functions as para-transcription factor to regulate gene expression and cell proliferation in non-cell autonomous manner.
Zhou J; Qin L; Tien JC; Gao L; Chen X; Wang F; Hsieh JT; Xu J
J Biol Chem; 2012 May; 287(21):17248-17256. PubMed ID: 22465996
[TBL] [Abstract][Full Text] [Related]
11. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia.
Abdulkadir SA; Magee JA; Peters TJ; Kaleem Z; Naughton CK; Humphrey PA; Milbrandt J
Mol Cell Biol; 2002 Mar; 22(5):1495-503. PubMed ID: 11839815
[TBL] [Abstract][Full Text] [Related]
12. [The specific expression profile of homeobox gene NKX3.1 mRNA and protein in prostate tissues and its relationship with primary prostate cancer].
Yang GS; Wang YM; Chen ZD
Zhonghua Nan Ke Xue; 2006 Feb; 12(2):137-40, 144. PubMed ID: 16519150
[TBL] [Abstract][Full Text] [Related]
13. Gene of the month: NKX3.1.
Griffin J; Chen Y; Catto JWF; El-Khamisy S
J Clin Pathol; 2022 Jun; 75(6):361-364. PubMed ID: 34996754
[TBL] [Abstract][Full Text] [Related]
14. Expression studies and mutational analysis of the androgen regulated homeobox gene NKX3.1 in benign and malignant prostate epithelium.
Ornstein DK; Cinquanta M; Weiler S; Duray PH; Emmert-Buck MR; Vocke CD; Linehan WM; Ferretti JA
J Urol; 2001 Apr; 165(4):1329-34. PubMed ID: 11257711
[TBL] [Abstract][Full Text] [Related]
15. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression.
Bowen C; Bubendorf L; Voeller HJ; Slack R; Willi N; Sauter G; Gasser TC; Koivisto P; Lack EE; Kononen J; Kallioniemi OP; Gelmann EP
Cancer Res; 2000 Nov; 60(21):6111-5. PubMed ID: 11085535
[TBL] [Abstract][Full Text] [Related]
16. Expression profile of an androgen regulated prostate specific homeobox gene NKX3.1 in primary prostate cancer.
Xu LL; Srikantan V; Sesterhenn IA; Augustus M; Dean R; Moul JW; Carter KC; Srivastava S
J Urol; 2000 Mar; 163(3):972-9. PubMed ID: 10688034
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of NKX3.1 in LNCaP prostate cancer cells by RNA interference.
Possner M; Heuser M; Kaulfuss S; Scharf JG; Schulz W; Hermann-Ringert R; Thelen P
Int J Oncol; 2008 Apr; 32(4):877-84. PubMed ID: 18360715
[TBL] [Abstract][Full Text] [Related]
18. Integration of regulatory networks by NKX3-1 promotes androgen-dependent prostate cancer survival.
Tan PY; Chang CW; Chng KR; Wansa KD; Sung WK; Cheung E
Mol Cell Biol; 2012 Jan; 32(2):399-414. PubMed ID: 22083957
[TBL] [Abstract][Full Text] [Related]
19. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.
Thomas MA; Preece DM; Bentel JM
Biochem J; 2010 Jan; 425(3):575-83. PubMed ID: 19886863
[TBL] [Abstract][Full Text] [Related]
20. Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis.
Ouyang X; DeWeese TL; Nelson WG; Abate-Shen C
Cancer Res; 2005 Aug; 65(15):6773-9. PubMed ID: 16061659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
